Online ISSN: 1945-4589
Learn about our FREE Post-Publication Promotion Services

Aging-US | WRNing for the Right DNA Repair Pathway Choice

06-16-2022

Listen to an audio version of this press release

BUFFALO, NY- June 16, 2022 – A new editorial paper was published in Aging (Aging-US) Volume 14, Issue 11, entitled, “WRNing for the right DNA repair pathway choice.”

Premature aging diseases, also called ‘progeroid syndrome’, display signs and features of normal aging in early life, ultimately leading to premature death. Although progeroid syndromes do not perfectly mimic chronological aging, they can be excellent model systems to study characteristics of normal aging. 

Werner syndrome (WS) is one of the rare autosomal recessive progeroid syndromes, characterized by accelerated aging. WRN is suggested to play a central role in maintaining genome stability and rapidly recruits to the DNA damage sites to take part in DNA repair, including base excision DNA repair (BER), classical/alternative non-homologous end joining (NHEJ), homologous recombination (HR), and replication re-start after DNA damage.  

WRN makes critical DNA-repair pathway choices between classical and alternative NHEJs. In addition to its key role in NHEJ, WRN has been suggested to also participate in HR. However, how it regulates the pathway choice between NHEJ and HR was still unclear.  

Jong-Hyuk Lee, Deborah L. Croteau and Vilhelm A. Bohr, from the National Institutes of Health’s National Institute on Aging, authored a new editorial paper about findings from their recent study. 

“In a recent paper, we showed that CDK2 phosphorylating WRN on serine residue 426 is critical for WRN to make its DNA double strand break (DSB) repair pathway choice between NHEJ and HR [4].”

Abnormal DSB recruitment, altered interaction with RPA, strand annealing activity, and DSB repair activities were observed when cells were forced to express WRN engineered to mimic the unphosphorylated or phosphorylation state at serine 426. 

“These findings along with the previous discovered role in NHEJ pathway choice, move our understandings one step closer to the true nature of genomic instability that lies within WS.”

Interestingly, another RECQL family member, RECQL4 has also been identified as one of the crucial decision makers during DSB repair pathway choice. A graphic representation of RecQs in DSB pathway choice is shown in Figure 1.


Figure 1. Points of control by human RecQ helicases in DSB repair pathway choice. 


Notably, primary fibroblast cells show similarly increased persistent DNA damage after WRN or RECQL4 knockdown, and CDK regulatory mechanisms on WRN and RECQL4 have functional similarities in DSB response.

“It is thus conceivable that investigating the cooperative roles of WRN and RECQL4 in DSB pathway choice should be a future goal for DNA repair and aging research.”

DOI: https://doi.org/10.18632/aging.204120 

Corresponding Author: Vilhelm A. Bohr - vbohr@nih.gov 

Keywords: DNA repair, RecQ helicase, helicase, DNA double strand repair pathways 

Sign up for free Altmetric alerts about this article:  https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204120 

Follow Aging on social media: 

For media inquiries, please contact media@impactjournals.com.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com and connect with us:

For media inquiries, please contact media@impactjournals.com.